Clinical Trials
4 trialsNCT06823375 2026-03-04
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
Chinese University of Hong Kong
Phase 2 Recruiting
NCT05873244 2025-03-21
CXD101 in Immunotherapy-related Liver Cancer
Chinese University of Hong Kong
Phase 2 Recruiting
NCT06413017 2024-05-14
Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT04123340 2023-01-06
IAMCOMPLETE
Leiden University Medical Center
Phase 2 Completed